Good Practices for Health Technology Assessment Guideline Development: A Report of the Health Technology Assessment International, HTAsiaLink, and ISPOR Special Task Force

被引:0
|
作者
Botwright, Siobhan [1 ,2 ]
Sittimart, Manit [1 ]
Chavarina, Kinanti Khansa [1 ]
Bayani, Diana Beatriz [3 ]
Merlin, Tracy [4 ]
Surgey, Gavin [5 ]
Suharlim, Christian [6 ]
Espinoza, Manuel A. [7 ]
Culyer, Anthony J. [8 ]
Oortwijn, Wija [5 ]
Teerawattananon, Yot [1 ,3 ]
机构
[1] Minist Publ Hlth, Hlth Intervent & Technol Assessment Program HITAP, Nonthaburi, Thailand
[2] Univ Strathclyde, Glasgow, Scotland
[3] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore
[4] Univ Adelaide, Adelaide Hlth Technol Assessment AHTA, Adelaide, SA, Australia
[5] Radboud Univ Nijmegen, Med Ctr, Nijmegen, Netherlands
[6] Management Sci Hlth, Medford, MA USA
[7] Pontificia Univ Catolica Chile, Santiago, Chile
[8] Univ York, Ctr Hlth Econ, York, England
关键词
evidence-informed priority setting; good practices; guidelines; HTA; BUDGET IMPACT ANALYSIS; ECONOMIC-EVALUATION; STAKEHOLDER INVOLVEMENT; PRINCIPLES; FRAMEWORK; MODEL; RECOMMENDATIONS; UNCERTAINTY; CONFLICTS; RESOURCE;
D O I
10.1016/j.jval.2024.09.001
中图分类号
F [经济];
学科分类号
02 ;
摘要
Objectives: Health technology assessment (HTA) guidelines are intended to support successful implementation of HTA by enhancing consistency and transparency in concepts, methods, process, and use, thereby enhancing the legitimacy of the decision-making process. This report lays out good practices and practical recommendations for developing or updating HTA guidelines to ensure successful implementation. Methods: The task force was established in 2022 and comprised experts and academics from various geographical regions, each with substantial experience in developing HTA guidelines for national health policymaking. Literature reviews and key-informant interviews were conducted to inform these good practices. Stakeholder consultations, open peer reviews, and expert opinions validated the recommendations. A series of teleconferences among task force members was held to iteratively refine the report. Results: The recommendations cover 6 key aspects throughout the guideline development cycle: (1) setting objectives, scope, and principles of the guideline, (2) building a team for a quality guideline, (3) defining a stakeholder engagement plan, (iv) developing content and utilizing available resources, (v) putting in place appropriate institutional arrangements, and (vi) monitoring and evaluating guideline success. Conclusion: This report presents a set of resources and context-appropriate practices for developing or updating HTA guidelines. Across all contexts, the recommendations emphasize transparency, building trust among stakeholders, and fostering a culture of ongoing learning and improvement. The report recommends timing development and revision of guidelines according to the HTA landscape and pace of HTA institutionalization. Because HTA is increasingly used to inform different kinds of decision making in a variety of country contexts, it will be important to continue to monitor lessons learned to ensure the recommendations remain relevant and effective.
引用
收藏
页码:1 / 15
页数:15
相关论文
共 50 条
  • [41] HEALTH TECHNOLOGY ASSESSMENT IN SURGERY
    Bergqvist, D.
    Rosen, M.
    SCANDINAVIAN JOURNAL OF SURGERY, 2012, 101 (02) : 132 - 137
  • [42] Health technology assessment in Singapore
    Pwee, Keng Ho
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2009, 25 : 234 - 240
  • [43] Multiple Criteria Decision Analysis for Health Care Decision Making-An Introduction: Report 1 of the ISPOR MCDA Emerging Good Practices Task Force
    Thokala, Praveen
    Devlin, Nancy
    Marsh, Kevin
    Baltussen, Rob
    Boysen, Meindert
    Kalo, Zoltan
    Longrenn, Thomas
    Mussen, Filip
    Peacock, Stuart
    Watkins, John
    Ijzerman, Maarten
    VALUE IN HEALTH, 2016, 19 (01) : 1 - 13
  • [44] Health research and Health Technology Assessment in Chile
    Antonio Espinoza, Manuel
    Cabieses, Baltica
    Paraje, Guillermo
    REVISTA MEDICA DE CHILE, 2014, 142 (01) : S39 - S44
  • [45] Designing collaborations involving health technology assessment: discussions and recommendations from the 2024 health technology assessment international global policy forum
    Trowman, Rebecca
    Migliore, Antonio
    Ollendorf, Daniel A.
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2024, 40 (01)
  • [46] State-Transition Modeling: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-3
    Siebert, Uwe
    Alagoz, Oguzhan
    Bayoumi, Ahmed M.
    Jahn, Beate
    Owens, Douglas K.
    Cohen, David J.
    Kuntz, Karen M.
    MEDICAL DECISION MAKING, 2012, 32 (05) : 690 - 700
  • [47] Model Parameter Estimation and Uncertainty: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-6
    Briggs, Andrew H.
    Weinstein, Milton C.
    Fenwick, Elisabeth A. L.
    Karnon, Jonathan
    Sculpher, Mark J.
    Paltiel, A. David
    VALUE IN HEALTH, 2012, 15 (06) : 835 - 842
  • [48] An Overview of Value, Perspective, and Decision Context-A Health Economics Approach: An ISPOR Special Task Force Report [2]
    Garrison, Louis P., Jr.
    Pauly, Mark V.
    Willke, Richard J.
    Neumann, Peter J.
    VALUE IN HEALTH, 2018, 21 (02) : 124 - 130
  • [49] A Conceptual Framework for Life-Cycle Health Technology Assessment
    Kirwin, Erin
    Round, Jeff
    Bond, Ken
    McCabe, Christopher
    VALUE IN HEALTH, 2022, 25 (07) : 1116 - 1123
  • [50] Establishing the Value of Diagnostic and Prognostic Tests in Health Technology Assessment
    Soares, Marta O.
    Walker, Simon
    Palmer, Stephen J.
    Sculpher, Mark J.
    MEDICAL DECISION MAKING, 2018, 38 (04) : 495 - 508